Yarrow Bioscience Inc (YARW) Financials
YARW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 23.6 million | 1.5 million |
| March 31, 2026 | 25.9 million | 1.2 million |
| Dec. 31, 2025 | 30.2 million | 2.4 million |
| Sept. 30, 2025 | 36.1 million | 4.0 million |
YARW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.0 million | 436000 |
| March 31, 2026 | -4.1 million | 474000 |
| Dec. 31, 2025 | -3.8 million | 529000 |
| Sept. 30, 2025 | -7.1 million | 487000 |
YARW Net Income
No data available :(
YARW Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 22.9 million | - | - |
| March 31, 2026 | 24.9 million | - | - |
| Dec. 31, 2025 | 29.0 million | - | - |
| Sept. 30, 2025 | 32.7 million | - | - |
YARW Shares Outstanding
YARW Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 788000 | 2.4 million | - |
| March 31, 2026 | - | 817000 | 3.1 million | - |
| Dec. 31, 2025 | - | 3.0 million | 2.4 million | - |
| Sept. 30, 2025 | - | 5.3 million | 2.7 million | - |
YARW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 97000 | - |
| March 31, 2026 | 86000 | 6000 |
| Dec. 31, 2025 | 130000 | - |
| Sept. 30, 2025 | 169000 | - |
YARW Revenue by Segment
Graph available only for paid members. Upgrade to see it.
YARW
Price: $36.42
52 week price:
Forward Dividend Yield: 0.04%
Dividend Per Share: 0.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 110.8 million
Average Dividend Frequency: 2
Years Paying Dividends: 1